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Hypertensive emergencies
Emergências hipertensivas
REVIEW ARTICLE
INTRODUCTION 
It is estimated that 3% of all visits to the emergency rooms are due to sig-
nificant elevation of the arterial pressure (AP). From 1% to 2% of hypertensive 
patients, at some point of time, present with a condition of increased AP re-
quiring urgent medical care1. Hypertensive emergency is one of the most severe 
clinical conditions that merit intensive care and is characterized by a markedly 
high AP and signs of target organ damage (encephalopathy ,acute infraction of 
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ABSTRACT
Emergencies and hypertensive crises 
are clinical situations which may represent 
more than 25% of all medical emergency 
care. Considering such high prevalence, 
physicians should be prepared to correctly 
identify these crises and differentiate be-
tween urgent and emergent hypertension. 
Approximately 3% of all visits to emergen-
cy rooms are due to significant elevation 
of blood pressure. Across the spectrum of 
blood systemic arterial pressure, hyperten-
sive emergency is the most critical clinical 
situation, thus requiring special attention 
and care. Such patients present with high 
blood pressure and signs of acute specific 
target organ damage (such as acute myo-
cardial infarction, unstable angina, acute 
pulmonary edema, eclampsia, and stroke). 
Key elements of diagnosis and specific 
treatment for the different presentations of 
hypertensive emergency will be reviewed 
in this article. The MedLine and PubMed 
databases were searched for pertinent ab-
stracts, using the key words “hypertensive 
crises” and “hypertensive emergencies”. 
Additional references were obtained from 
review articles. Available English language 
clinical trials, retrospective studies and re-
view articles were identified, reviewed and 
summarized in a simple and practical way..
The hypertensive crisis is a clinical situa-
tion characterized by acute elevation of 
blood pressure followed by clinical signs 
and symptoms. These signs and symptoms 
may be mild (headache, dizziness, tinni-
tus) or severe (dyspnea, chest pain, coma 
or death). If the patient presents with mild 
symptoms, but without acute specific tar-
get organ damage, diagnosis is hyperten-
sive urgency. However, if severe signs and 
symptoms and acute specific target organ 
damage are present, then the patient is 
experiencing a hypertensive emergency. 
Some patients arrive at the emergency 
rooms with high blood pressure, but with-
out any other sign or symptom. In these 
cases, they usually are not taking their 
medications correctly. Therefore, this is 
not a hypertensive crisis, but rather non-
controlled chronic hypertension. This type 
of distinction is important for those work-
ing in emergency rooms and intensive care 
unit. Correct diagnosis must be made to 
assure the most appropriate treatment. 
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the myocardium, unstable angina, acute pulmonary edema, 
eclampsia and stroke)1,2-7. Brooks et al., in a retrospective 
study with 427 patients treated by intravenous antihyper-
tensive therapy for more than 30 min in the emergency 
ward or intensive care unit (ICU) identified that 57% were 
considered “excessively managed” and 11% failed in the 
treatment adopted for the acute stage within 6 hours.8 Forty 
four patients presented with relevant adverse events related 
to excessive decrease of the mean arterial pressure (MAP).
In prospective studies, Baumann et al., when evaluat-
ing prevalence of hypertensive patients in the emergency 
ward showed that most of them are young, male, smokers, 
regular alcohol consumers and that 1/3 had no former his-
tory of hypertension or is under non-optimal control.9
In Brazil, Sobrinho et al., comparing data from public 
and private hospitals assessed independent predictors for 
pseudo hypertensive crises.10 Prevalence was of 48% (95% 
CI = 39%-58%) and higher in private hospitals (59% versus 
37%, p = 0.02); frequency of incorrect diagnosis was similar 
between the hospitals (94% versus 95%, p = 0.87). 
DEFINITIONS
Hypertensive crisis is a clinical condition with a 
sudden elevation of AP (≥ 180 x 120 mmHg), together 
with symptoms that may be mild (headache, dizziness, 
tinnitus) or severe (dyspnea, chest pain, coma and even 
death), with or without acute target organ damage. A 
hypertensive crisis is defined when symptoms are mild 
and there is no acute target organ damage. On the 
other hand, a hypertensive emergency is when symp-
toms endanger the patient’s life, with acute target organ 
damage.2,3,11 
In the pseudo hypertensive crisis, elevation is 
solely due to physical or psychological stress (i.e. 
pain). Many patients present with an excessive AP 
simply because they do not take their medication or 
because they are unaware bearers of systemic arte-
rial hypertension. That is to say, they have non con-
trolled chronic systemic arterial hypertension (Chart 
1 and Figure 1).3,7,8,11
Chart 1 – Findings of the history and physical exam of the different hypertensive emergencies
Hypertensive emergencies History Physical Exam Comments
Acute pulmonary edema Distressed patient with speech 
difficulty. Generally already 
presents some degree of ventri-
cular dysfunction 
Apex pulmonary rales. Low 
oxygen saturation
B3 and/or B4
May have stasis of the jugulars 
(not mandatory)
Sometimes there may be signi-
ficant wheezing , questioning 
the differential diagnosis of 
asthma 
Acute coronary syndrome Pain or feeling of oppressive 
chest pain.
May be with nausea, dyspnea 
or cold sudoresis
 Present B4 
In general poor propedeutic 
findings 
Careful characterization of pain 
is the most important stage of 
ACS investigation
Acute aortic dissection Agonizing pain may be precor-
dial or irradiate to the back.
May have asymmetric pulses.
May have diastolic murmur in 
aortic focus 
Must be differentiated from 
ACS
Hypertensive encephalopathy Lethargy, headache, confusion, 
vision disorders and seizures, 
all with an acute or subacute 
onset
Physical exam may not disclose 
any finding.
Usually stroke must be exclu-
ded by TC Scan
Malignant hypertension Asthenia, malaise, 
weight loss, oliguria vagus car-
diovascular and/or neurological 
symptoms
Eye papilledema Potentially fatal, diagnosis as 
early as possible can only be 
made by fundoscopy 
Ischemic stroke candidate to 
trombolisis or hemorrhagic 
Sudden neurological 
alteration(usually motor or 
sensory) 
Alteration at neurological exam Main differential diagnosis 
is of hypo or hyperglycemia. 
Attention to sudden headache 
(subarachnoid hemorrhage)
Eclampsia Pregnant after the 20th week 
of pregnancy or until 6th week 
after delivery
Previous diagnosis of pree-
clampsia and evolves to seizures
 ACS – acute coronary syndrome
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Figure 1 - Differential diagnosis of the arterial pressure ele-
vations.
Semiology of hypertensive emergencies 
Propedeutic procedure with hypertensive emergency 
patients begins with an AP above 180 x 120mmHg, al-
though this pressure level is not absolutely obligatory. 
Patients with a lesser functional reserve of given organs 
may present with hypertensive emergency at lower pres-
sure levels. Of fundamental importance is how fast AP 
increases. Normotensive patients who did not have time 
to establish self-regulatory mechanisms are more sensitive. 
AP levels alone do not diagnose an emergency, urgency or 
pseudocrisis.3-5 
If the patient was previously hypertensive it is impor-
tant to know about his pressure control, use of antihyper-
tensive drugs, dosage, adherence and when the last tablet 
was taken. Information about drug consumption (co-
caine, amphetamines) or monoxidase (MAO) inhibitors 
must be queried. Renal impairment may be disclosed by 
presence of oliguria or hematuria. Measuring of AP must 
be done with a cuff of appropriate size sphygmomanom-
eter. Physical exam must search for target organ damage 
by pulse palpation of all limbs, pulmonary auscultation 
and signs of congestion, heart auscultation for murmurs 
and gallops and renal artery murmurs. Fundoscopy must 
always be made in patients with suspicion of a hyperten-
sive crisis.2,4,5,12    
 “White coat” hypertension is a common and well 
known occurrence in day care units but forgotten in 
emergency wards despite the frequency and association to 
the worst morbidity when present before the hypertensive 
event.13 
In intensive care medicine it is fundamental to be 
aware of pain (even in sedated patients with inadequate 
analgesia), effect of other agents, rise of catecholamines, 
postoperative hypertension and hyperevolemia. In such 
patients additional cares are needed to avoid, with rare 
exceptions (aortic dissection), decrease of MAP over 10% 
to 20% in the first hours, and afterwards 15% in the two 
to three subsequent hours, thereby avoiding induction of 
severe ischemia of noble organs (brain, heart and suprare-
nals), permitting adjustment of the self-regulatory mecha-
nisms.6,8,14,15 
COMPLEMENTARY EXAMS 
All patients with hypertensive emergency must under-
go the following exams:
complete blood test, serum urea, serum creatinine, 
electrolytes (sodium, potassium, magnesium), type I urine 
(search for proteinuria or microscopic hematuria), chest 
X-ray, electrocardiogram and capillary glycemia.
Comparisons of the last results with former exams 
may help to determine how acute the specific target organ 
damage is.5-7
In addition to these general exams, other specific ones 
will depend upon the type of hypertensive emergency 
found (Chart 2).
Chart 2 – Specific exams according to each type of hypertensive emergency
Hypertensive emergencies Specific exam for this emergency
Acute pulmonary edema Serum BNP (echocardiogram if available) 
Acute coronary syndrome Markers of myocardial necrosis (always), cineangiocoronarygraphy (almost always)
Acute aortic dissection CT scan, transesophageal echocardiogram, angioresonance, angiography 
Hypertensive encephalopathy CT scan to exclude stroke 
Malignant hypertension Nothing in particular 
Stroke Brain CT scan 
Eclampsia Nothing in particular 
BNP- B-type natriuretic peptide. CT- computed tomography
Symptoms
Yes No
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TREATMENT 
Patients must be admitted and initially cared for in the 
emergency ward and later transferred to the ICU later.
Patients must be monitored with regard to the elet-
rocardiogram tracing, pulse oxymetry and AP and given 
some source of oxygen. Venous access must be obtained 
for administration of vasodilating drugs. 
A decrease of about 10% to 20% of MAP is suggested 
during the first hour7. Hypoperfusion may result when AP 
is abruptly reduced. Invasive monitoring of AP is needed 
if high doses of intravenous vasodilators are required or 
when, for any technical reason, noninvasive pressure is not 
reliable. After six hours of parenteral treatment, oral an-
tihypertensive maintenance therapy must be undertaken. 
Arterial pressure may be reduced to normal in the next 24 
to 48 hours, with gradual decrease of parenteral adminis-
tration. During the entire treatment patient must remain 
euvolemic (Chart 3).3-6
THERAPEUTIC ARMAMENTARIUM 
To treat hypertensive emergencies the ideal drug must 
have a rapid action, quickly reversible and with no side 
effects, which of course makes it unreal.6-9,11 In a system-
atic review Cherney evaluated four studies of hypertensive 
emergencies and 15 of hypertensive crises to conclude 
that various drugs were efficient (urapadil, nitroprussi-
ate, nicardipine, lacidipine, nifedipine, enalaprilate and 
fenoldopam).16 However, attention was directed to cases 
of cerebral ischemia related to use of nifedipine. Unfortu-
nately, because of the few randomized studies in this clini-
cal scenario, many questions remain unanswered about 
the long term follow-up of really beneficial, specific agents 
in relevant endpoints with a decrease of mortality.
The main parenteral drugs available in Brazil are:
1) Sodium nitroprussiate6,9-11,15,17-18 – a vasodilator of 
immediate action and short duration whose molecule is 
formed by a ferric core, five cyanate ions and a group of 
nitric acid. When it interacts with the sulphydryil groups 
of blood cells and the vascular wall, cyanate ions and the 
nitric oxide group are released, the latter acting as a direct 
vasodilator. It is the most effective parenteral drug for hy-
pertensive emergencies. It has greater action on the arterial 
system than on the venous system. It acts very quickly (in 
seconds) and its action lasts for 1 to 2 minutes, with a 
plasmatic life of 3 to 4 minutes. Therefore, abrupt cessa-
tion of the infusion will cause an almost immediate eleva-
tion of the pressure. 
Despite its ideal pharmacodynamic and pharmacoki-
Chart 3 – Treatment of the pressure levels for each type of hypertensive emergency
Hypertensive emergencies Treatment of pressure levels (in chronological order of administration) 
Acute pulmonary edema Sublingual nitrate
Intravenous furosemide
Intravenous morphine
Intravenous sodium nitroprussiate, (if SBP > 180 mmHg) or nitroglycerin (if 
SBP < 180 mmHg)
Acute coronary syndrome (ACS) Sublingual Nitrate 
Intravenous morphine 
Intravenous beta-blocker 
Intravenous sodium nitroprussiate, (if SAP > 180 mmHg) or nitroglycerin (if 
SBP < 180 mmHg
Acute aortic dissection Intravenous beta-blocker 
Intravenous morphine 
Intravenous sodium nitroprussiate
Hypertensive encephalopathy Intravenous sodium nitroprussiate
Malignant hypertension Intravenous sodium nitroprussiate
Ischemic stroke candidate to thrombolysis or 
hemorrhagic 
Intravenous sodium nitroprussiate
Add oral nimodipine if subarachnoid hemorrhage
Eclampsia Intravenous hydralazine 
Excess of catecholamines Intravenous alpha-blocker (fentolamine) 
Benzodiazepine
Intravenous beta-blocker 
SBP- systolic blood pressure
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netic profile, nitroprussiate has restrictions, mainly when 
used for an extended period (> 24-48 hours) and/or in 
high doses (> 2 µg/kg/min). Particularly, in patients with 
renal or hepatic dysfunction it may lead to cyanate in-
toxication that can manifest itself as metabolic acidosis, 
mental disturbance, such as encephalopathy, headache 
and unexplained cardiac arrest. If doses between 4 and 
10 µg/kg/min are being used, an infusion of thiosulphate 
may be administered to prevent cyanate deposit, as well 
as continued infusion of hydroxycobalamine (safe and ef-
ficient in the prevention and treatment of cyanate toxicity 
associated with nitroprussiate). Thiocyanate intoxication 
(originated by cyanate when metabolized in the liver) is 
also possible in such conditions although less severe. In 
patients with coronary disease, significant reduction of the 
afterload may reduce coronary arterial flow. In a random-
ized placebo-controlled clinical trial, nitroprussiate in-
creases mortality in 13 weeks (24.2% versus 12.7%) when 
administered in the first hours after acute infarction of the 
myocardium.2-3
When given, it must be protected from light, because 
it is photosensitive. Initially 0.25 µg/kg/min may be given 
and then increased every 2 minutes until the desired AP 
is reached. In practice, an ampoule of sodium nitroprussi-
ate (50 mg) is diluted in 250mL of saline solution, bottle 
and line must be protected from light and, by means of 
an infusion pump, it is administered at 3 mL/h. AP must 
then be measured every two minutes and each time, if still 
above the desired level, 1 or 2 mL/h should be increased. 
When the desired AP is reached, an oral antihypertensive 
may be given, preferably with a short mean-life to begin 
the strategy of reducing infusion speed, ideally with an 
invasive AP or, in its absence, using a noninvasive monitor 
of AP, with measurement every 10 minutes.
2) Nitroglycerin17-20 - interacts with the nitrate receptors 
of the vessels’ smooth muscles. It must be administered in 
glass or polyethylene flasks and conveyed by polyethylene 
equipment. It has a much more powerful action in venous 
dilation than in arterial dilation. Sometimes its arterial ac-
tion is insufficient to satisfactorily reduce AP. Furthermore 
it has the capacity to dilate epicardial coronary vessels, one 
of the reasons for its use as anti-angina agent. Possible side 
effects are: headache, vomit, tachycardia and hypotension. 
Rarely, it may cause bradycardia or methemoglobinemia. 
It is contraindicated in cases of right ventricular infarc-
tion and in patients who have used sildenafil in the last 24 
hours. Patients may develop tolerance if it is used for long 
periods. Peak action occurs in 2 to 5 minutes and effect 
lasts for 5 to 10 minutes. Initial dose is of 5 µg/min and 
may be increased every 5 to 10 minutes if the target-AP 
has not been attained. In practice, 50 mg may be diluted 
in 250mL of saline solution 0.9% taking care of the bag 
and line. Administration is intravenous with 3mL/h in an 
infusion pump and increased 2mL/h every 5 minutes, un-
til the desired AP is reached or a side effect occurs (head-
ache is the most frequent).
3) Beta-blockers7-10,15 - intravenous metoprolol and 
propranolol are the most often available in Brazil. They are 
used when a decrease of the heart rate is the major concern 
even more so than a decrease of AP. They are contraindi-
cated in patients with decompensated ventricular failure, 
bearers of decompensated chronic obstructive pulmonary 
disease (COPD) or asthma, severe peripheral vasculopathy 
and atrioventricular blocks. Metoprolol is more beta-1 se-
lective that propranolol. Both must be administered intra-
venously by a slow bolus, without any dilution and can be 
repeated up to 3 times or until the target heart rate is met. 
If beta-blockers cannot be used because of some contrain-
dication, a venous calcium antagonist that has a negative 
chronotropic effect such as verapamil or diltiazem (the lat-
ter has the advantage of being less inotropic-negative) may 
be used. These calcium antagonists are contraindicated in 
presence of atrioventricular blocks and relatively contrain-
dicated in presence of ventricular failure. 
4) Hydralazine4,13,14 - is a direct arteriolar vasodilator 
with quick onset of action (5 to 15 minutes) and pro-
longed duration (2 to 6 hours). It is metabolized by the 
liver and eliminated in the urine; therefore doses must be 
reduced in cases of renal or hepatic diseases. It may cause 
reflex tachycardia contraindicating its use in acute coro-
nary syndromes and in acute aortic dissection. Usually, it 
is used in hypertensive emergencies for pregnant women 
because of its proven safety for the fetus. Side effects are 
that it may induce rheumatological or immunological dis-
eases and its interruption is usually curative. 
THERAPY ACCORDING TO EACH TYPE OF 
HYPERTENSIVE EMERGENCY
Acute pulmonary edema   
Acute hypertensive pulmonary edema must be imme-
diately managed with sublingual nitroglycerin, furosemi-
de and intravenous morphine. The patient must be sitting, 
preferentially with the legs dangling out of the gurney. Use 
of noninvasive mechanical ventilation has proven to be 
one of the most important measures to resolve the symp-
toms. The antihypertensive to be used is, in general, nitro-
prussiate.5,6,15-19
Intravenous nitroglycerin is preferred in the case of 
heart disease or when AP is not too high (arbitrarily a sys-
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tolic pressure of less than 180mmHg may serve as criteri-
on). For bearers of mitral stenosis with a good ventricular 
function, an intravenous beta-blocker may be used.
Acute aortic dissection 
A potent analgesia must be achieved with morphine 
and the heart rate must be reduced to about 60 bpm 
with intravenous metoprolol. In dissection it is more im-
portant to reduce heart rate than to reduce AP. Once 
both actions have been taken, AP may eventually reach 
sufficiently low levels to avoid additional administration 
of intravenous antihypotensive. Acute aortic dissection is 
one of the exceptions where AP must be reduced to lower 
levels, with in general, a systolic AP of about 100 to 110 
mmHg in the first 20 minutes of treatment  Therefore 
it is often necessary to use another vasodilator which is 
usually sodium nitroprussiate. If there is coronary im-
pairment in aortic dissection, intravenous nitroglycerin 
will be preferred.5,6,15-19
Acute coronary syndrome (ACS) 
Initial pressure control is done with sublingual ni-
trate, followed by intravenous morphine if pain does not 
abate. After achieving venous access a beta-blocker must 
be administered until the heart rate is reduced. Then ni-
troglycerin is given continuously at a tittered speed to 
reduce AP by 30%. A very abrupt reduction must be 
avoided as it may reduce coronary perfusion. Further-
more, this chapter does not intend to approach details 
on how to manage ACS, but only to show the arma-
mentarium available for pressure control in these cases. 
Angiotensin converter enzyme (ACE) inhibitors may be 
a significant drug for these patients, even if they become 
normotensive as the action is favorable on the processes 
of ventricular remodeling.5,6,15-19
However, among the antihypertensives discussed here, 
this is the last to be administered, because its benefits are 
over the long tem and the drugs already described are 
more important for acute control of the painful condi-
tion. That is why it must be administered only after the 
clinical condition is stable and at least 6 hours after onset 
of the acute event. 
Hypertensive encephalopathy 
With sudden elevation of AP, the upper threshold of 
the self-regulatory capacity of the cerebral blood flow may 
be surpassed with consequent hyper cerebral perfusion 
leading to an endothelial dysfunction, rupture of the he-
matoencephalic barrier, cerebral edema and micro hemor-
rhages. The clinical outcomes are hypertensive encephal-
opathy characterized by acute or subacute appearance of 
some symptoms such as lethargy, headache, confusion, 
vision disorders and seizures. Usually, these patients are 
not hypertensive before the event. A computed tomogra-
phy scan of the brain will always be required to exclude 
other neurological affections, mainly stroke. AP must be 
reduced by some 20% and the drug chosen is sodium ni-
troprussiate.5-6,15-19 
Malignant hypertension     
Manifests itself by neuroretinopathy and acute or 
subacute renal failure. The patient in general exhibits as-
thenia, malaise, weight loss and cardiovascular or neuro-
logical symptoms. If not properly treated, mortality is of 
approximately 90% in one year. Renal failure may range 
from previously inexistent proteinuria to overt acute re-
nal failure. Traditionally, retinopathy manifests itself by 
papilledema at the eye, corresponding to a stage IV retin-
opathy in the Keith Wagener classification. Treatment is 
with sodium nitroprussiate until a 20% decrease of AP 
in 2 hours, followed by gradual pressure control in 2 or 3 
days with oral medication. There are authors who believe 
that patients with mild symptoms, papilledema and slight 
loss of renal function may be managed as non-emergency 
hypertensive crises, that is to say, with no intravenous ad-
ministration of antihypertensives.2,7,14-18
Stroke 
Often an elevated AP is found during a stroke there-
fore raising the frequent doubt if AP is the cause or the 
consequence of the cerebral event. Most patients do not 
require any treatment for pressure control because once 
pain, anxiety and distress are controlled the AP tends to 
remain near normal values. Hypertension at this acute 
stage may be a beneficial effect to protect cerebral per-
fusion in the penumbra area. However, under certain 
conditions treatment is necessary. According to recom-
mendations standardized by the American Heart Asso-
ciation, with slight adaptations, use of nitroprussiate is 
suggested when AP >180 x 105 mmHg in patients with 
hemorrhagic or ischemic stroke, candidates to throm-
bolysis. Patients with ischemic stroke, excluding those 
that meet the criteria for thrombolysis, in general must 
be treated as hypertensive crisis, initially providing relief 
from pain and anxiety. If both factors are controlled and 
the patient continues to present AP> 22 x 120 mmHg, 
nitroprussiate may be used to reduce AP by 10% to 20% 
in 24 hours. Arterial pressure, usually, drops spontane-
ously to the levels prior to ischemic stroke in 4 days, 
without any antihypertensive treatment In subarachnoid 
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hemorrhage, the same procedures suggested for hemor-
rhagic stroke are pertinent, however nimodipine must be 
the first agent of the therapeutic armamentarium for this 
condition, as it reduces risk of cerebral infraction associ-
ated to vasospasm. For any stroke condition, the neuro-
logical worsening associated to a decrease of AP must be 
treated by reducing or even interrupting nitroprussiate 
administration.15-20 
Eclampsia   
It is defined as appearance of proteinuria and arte-
rial hypertension after the 20th week of pregnancy and 
until the 6th week after delivery. Generally it is accompa-
nied by edemas. Five percent of pregnant women bear-
ers of preeclampsia evolve to seizures, that characterize 
eclampsia. Although there are various control measures 
for this disease and to prevent the evolution, only deliv-
ery with removal of the placenta will reverse the entire 
physiopathology involved in this morbid process. That is 
why, whenever preeclampsia appears after the 36th week 
of pregnancy, the conduct is to anticipate delivery. If it 
is a case of severe preeclampsia or eclampsia, fetal ma-
turity must be verified by amniocentesis. Experienced 
physicians must then decide upon delivery or follow a 
strictly drug approach while fetal maturity is provoked 
with corticoids. In eclampsia, the agent chosen for pres-
sure control is hydralazine as it does not damage the fe-
tus. The use of sodium nitroprussiate is only authorized 
when delivery is imminent and pressure control is not 
achieved with intravenous hydralazine. The goal should 
be to keep systolic AP between 140 and 160 mmHg and 
diastolic AP between 90 and 105 mmHg.15-18
Hypertensive emergencies caused by excess of  
cathecolamines 
True hypertensive emergencies caused by excess of 
cathecolamines are rare. The main causes are pheochro-
mocytoma, users of MAO inhibitors that ingest food 
containing tyramine, cocaine or amphetamine users or 
sudden interruption of antihypertensives such as cloni-
dine and beta-blockers (easily manipulated by restarting 
treatment). Occasionally pheochromocytomas present 
with the typical triad of headache, sudoresis and severe 
hypertension. Treatment of hypertensive emergencies 
caused by pheochromocytoma or cocaine begins with an 
intravenous alfa-blocker (fentolamine). Benzodiazepine 
and a beta-blocker may next be added, however must be 
avoided initially to prevent unopposed alpha-adrenergic 
activity, with potential elevation of the arterial pressure 
(Table 1).3,4,9,13-15
CONCLUSION 
Hypertensive emergency consists of a syndrome where 
significant elevation of the systemic arterial pressure leads 
to acute target-organ damage, threatening life. Energetic 
measures must be taken for immediate treatment, initially 
with intravenous administration of drugs to reduce arte-
rial pressure. Sodium nitroprussiate is the most often used 
drug, but in some cases it may not be the best. To recog-
nize the disease in question and know how to properly 
treat it may be the difference between life and death in a 
few hours or minutes.
RESUMO
As urgências e as emergências hipertensivas são ocor-
rências clínicas que podem representar mais de 25% dos 
atendimentos a urgências médicas. O médico deverá estar 
habilitado a diferenciá-las, pois o prognóstico e o trata-
mento são distintos. Estima-se que 3% de todas as visitas 
às salas de emergência decorrem de elevações significativas 
da pressão arterial. Nos quadros relacionados a estes atendi-
mentos, a emergência hipertensiva é a entidade clínica mais 
grave que merece cuidados intensivos. É caracterizada por 
pressão arterial marcadamente elevada e sinais de lesões de 
órgãos-alvo (encefalopatia, infarto agudo do miocárdio, an-
gina instável, edema agudo de pulmão, eclâmpsia, acidente 
vascular encefálico). O objetivo deste estudo foi apresentar 
os principais pontos sobre o seu apropriado diagnóstico e 
tratamento. Foi realizada busca por artigos originais com os 
unitermos “crise hipertensiva” e “emergência hipertensiva” 
nas bases de dados Pubmed e MedLine nos últimos dez anos. 
As referências disponíveis destes artigos foram verificadas. Os 
artigos foram identificados e revisados e o presente estudo 
condensa os principais resultados descritos. Para esta revisão 
foram considerados ensaios clínicos em língua inglesa, estu-
dos retrospectivos e artigos de revisão. A crise hipertensiva é 
a entidade clínica com aumento súbito da PA (≥ 180 x 120 
mmHg), acompanhada por sintomas, que podem ser leves 
(cefaléia, tontura, zumbido) ou graves (dispnéia, dor precor-
dial, coma e até morte), com ou sem lesão aguda de órgãos-
alvo. Se os sintomas forem leves e sem lesão aguda de órgãos 
alvos, define-se a urgência hipertensiva. Se o quadro clínico 
apresentar risco de vida e refletir lesão aguda de órgãos-alvo 
tem-se, então, a emergência hipertensiva. Muitos pacientes 
também apresentam uma PA elevada demais, por não usarem 
suas medicações, tratando-se apenas de hipertensão arterial 
sistêmica crônica não controlada. Este conhecimento deve 
ser rotineiro ao emergencista e intensivista no momento de 
decidir sobre a conduta.
 
Descritores: Emergências; Hipertensão/complicações; Hip-
ertensão/diagnóstico; Hipertensão/terapia
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